ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

78 filings reported holding PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share as of Q3 2021.
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 39,831,678 shares of 105,365,368 outstanding shares and own 37.8% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (6,443,113 shares), WELLINGTON MANAGEMENT GROUP LLP (5,351,845 shares), FMR LLC (4,793,273 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4,715,152 shares), GOLDMAN SACHS GROUP INC (3,432,069 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2,079,668 shares), JENNISON ASSOCIATES LLC (1,841,578 shares), Opaleye Management Inc. (1,424,200 shares), FIL Ltd (1,205,760 shares), and GILDER GAGNON HOWE & CO LLC (1,152,912 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.